Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Zalcitabine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 19,230Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2Blank

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Zalcitabine
    arrow
    ICHH-25
    Not Confirmed

    Country
    arrow
    ICHH-25
    Not Confirmed

    Patent Expiration Date : 2007-12-18

    Date Granted :

    Zalcitabine

    Brand Name :

    Patent Number : 1277915

    Filing Date :

    Strength per Unit :

    Dosage Form :

    Human Or VET :

    Route of Administration :

    Patent Expiration Date : 2007-12-18

    Date Granted :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Zalcitabine
    arrow
    ICHH-25
    Not Confirmed

    Country
    arrow
    ICHH-25
    Not Confirmed

    Patent Expiration Date : 2007-12-18

    Date Granted :

    Zalcitabine

    Brand Name :

    Patent Number : 1277915

    Filing Date :

    Strength per Unit :

    Dosage Form :

    Human Or VET :

    Route of Administration :

    Patent Expiration Date : 2007-12-18

    Date Granted :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF